Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?

Br J Anaesth. 2021 Mar;126(3):e106-e108. doi: 10.1016/j.bja.2020.12.020. Epub 2020 Dec 17.

Authors

Lene H Garvey¹, Shuaib Nasser²

Affiliations

¹ Allergy Clinic, Department of Dermatology and Allergy, Copenhagen University Hospital, Gentofte, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: lene.heise.garvey@regionh.dk.
² Department of Allergy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

No abstract available

Keywords: COVID-19; allergy; anaphylaxis; drug allergy; hypersensitivity; polyethylene glycol; vaccine.

Publication types

Letter

MeSH terms

Anaphylaxis / chemically induced*
Anaphylaxis / diagnosis*
COVID-19 Vaccines / administration & dosage*
COVID-19 Vaccines / adverse effects
Humans
Polyethylene Glycols / administration & dosage
Polyethylene Glycols / adverse effects*
Surface-Active Agents / administration & dosage
Surface-Active Agents / adverse effects

Substances

COVID-19 Vaccines
Surface-Active Agents
Polyethylene Glycols